Valuation DexCom, Inc. Sao Paulo
Stocks
D1EX34
BRD1EXBDR004
Medical Equipment, Supplies & Distribution
|
Market Closed -
Sao Paulo
09:01:00 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 8.570 BRL | -7.95% |
|
+1.06% | +14.42% |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 32,445 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 25.34% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 31,684 | 31,384 | 30,569 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 20.89% | -0.95% | -2.6% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 34.5x | 29.1x | 24.1x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.4x | 9.51x | 7.32x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.6x | 1.2x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 6.2x | 5.6x | 5.03x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 6.06x | 5.42x | 4.74x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 19x | 16.4x | 13.9x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 25.4x | 21.7x | 17.8x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 31x | 25.7x | 20.8x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.22% | 3.89% | 4.81% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.489 | 2.952 | 3.562 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,229 | 5,793 | 6,446 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,666 | 1,918 | 2,203 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,248 | 1,444 | 1,714 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 973.1 | 1,146 | 1,401 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -761.1 | -1,061 | -1,877 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 85.98 | 85.98 | 85.98 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 377,361 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.95x | 4.09x | 15.82x | 2.45% | 180B | |
| 20.26x | 3.52x | 12.59x | 2.99% | 114B | |
| 22.98x | 4.5x | 15.69x | 1.22% | 114B | |
| 27.35x | 2.68x | 10.75x | 2.64% | 78.39B | |
| 18.7x | 0.22x | 13.49x | 0.7% | 64.88B | |
| 31.17x | 7.75x | 19.98x | 1.28% | 54.02B | |
| 36.95x | 3.53x | 12.1x | 2.05% | 51.96B | |
| 37.95x | 9.42x | 26.36x | -.--% | 43.79B | |
| 34.57x | 6.06x | 19.03x | -.--% | 32.45B | |
| Average | 28.99x | 4.64x | 16.20x | 1.48% | 81.49B | |
| Weighted average by Cap. | 27.60x | 4.21x | 15.37x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- D1EX34 Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
